Literature DB >> 6370489

Microvascular responses to E. coli endotoxin with altered adrenergic activity.

C H Baker, F R Wilmoth.   

Abstract

The cremaster muscle microcirculation of pentobarbital-anesthetized Wistar rats was studied using videomicroscopy. The left cremaster muscle was spread over an optical port in a bath filled with modified Krebs solution (pH 7.4, 34 degrees C). The right femoral artery was cannulated for determination of mean arterial pressure (Pm). Following control measurements of Pm and arteriolar and venular dimensions, dose-response curves of arteriolar and venular dimensions to topical norepinephrine (10(-10) M to 10(-3) M) was obtained. The rats were then administered E. coli endotoxin (6 mg/kg, iv, LD100) over a 1-hr period. The dose response curves were than repeated at intervals of 30 min. Before endotoxin the threshold dose for norepinephrine was consistently 10(-9) M or 0(-8) M. Pm decreased progressively with time postendotoxin. After endotoxin infusion, there was a gradual and progressive constriction of both arterioles and venules. The threshold dosage for norepinephrine to produce constriction of both arterioles and venules increased progressively with time. At 3 hr postendotoxin the threshold dose had increased to 10(-6) M to 10(-4) M. This is the dose that produces maximum constriction of arterioles in the preendotoxin control period. The study was terminated when the animal died or the field was obscured by petechiae. The microvessel sensitivity to norepinephrine is markedly reduced during endotoxin shock possibly due to increase in the active state of the vascular smooth muscle or to change in length of the muscle fibers or to changes in sympathetic alpha-adrenergic activity. The response was not prevented by H1 and H2 receptor blockade, but was prevented by alpha-adrenergic blockade with phentolamine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370489

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  12 in total

1.  Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.

Authors:  Martin W Dünser; Andreas J Mayr; Volker Wenzel; Walter R Hasibeder
Journal:  Intensive Care Med       Date:  2004-07-23       Impact factor: 17.440

2.  Hemodynamic management of septic shock.

Authors:  Daniel De Backer
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

Review 3.  Haemodynamic monitoring. Problems, pitfalls and practical solutions.

Authors:  L L Bossaert; H E Demey; R De Jongh; L Heytens
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  Microvascular perfusion is impaired in a rat model of normotensive sepsis.

Authors:  C Lam; K Tyml; C Martin; W Sibbald
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 5.  The concept of a critical oxygen delivery.

Authors:  P T Schumacker; S M Cain
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 6.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

Review 7.  Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.

Authors:  Stephen Trzeciak; Ismail Cinel; R Phillip Dellinger; Nathan I Shapiro; Ryan C Arnold; Joseph E Parrillo; Steven M Hollenberg
Journal:  Acad Emerg Med       Date:  2008-05       Impact factor: 3.451

8.  Metabolic fate of arachidonic acid in hepatocytes of continuously endotoxemic rats.

Authors:  E B Rodriguez de Turco; J A Spitzer
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

9.  The microcirculation in sepsis.

Authors:  Asha Tyagi; Ashok Kumar Sethi; Gautam Girotra; Medha Mohta
Journal:  Indian J Anaesth       Date:  2009-06

10.  From macrohemodynamic to the microcirculation.

Authors:  Abele Donati; Roberta Domizi; Elisa Damiani; Erica Adrario; Paolo Pelaia; Can Ince
Journal:  Crit Care Res Pract       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.